Ketipinor (Quetiapine)

Quetiapine modulates neurotransmission by blocking serotonin 5‑HT2A and dopamine D2 receptors while partially stimulating 5‑HT1A receptors. This combined antagonism and partial agonism helps balance mood, perception and thought processes that are disrupted in psychotic and mood disorders.

The prescribed dose of Ketipinor is individualized by the treating clinician based on the specific diagnosis, severity of symptoms, patient age, metabolic status and any concomitant medications. Dosage adjustments are made according to therapeutic response and tolerability.

Safety data for quetiapine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and decisions should be made in consultation with a qualified healthcare professional.

To request Ketipinor, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketipinor (quetiapine) and risperidone are both atypical antipsychotics but differ in receptor binding profiles. Quetiapine has stronger antihistaminic and sedative effects, while risperidone shows higher potency at dopamine D2 receptors and may have a lower risk of weight gain but a higher risk of prolactin elevation.

Ketipinor should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from excess moisture, direct sunlight and extreme heat to maintain its stability and potency.

Ketipinor is taken orally, usually in tablet form, with or without food as directed by the prescribing clinician. The medication is swallowed whole and should not be crushed or chewed unless specifically advised by a healthcare professional.

Serious risks include neuroleptic malignant syndrome, agranulocytosis, and cardiac arrhythmias such as prolonged QT interval. Patients should be monitored for fever, muscle rigidity, signs of infection, or any cardiac symptoms, and seek immediate medical attention if they occur.

Ketipinor should be avoided in individuals with known hypersensitivity to quetiapine or any of its excipients, in patients with uncontrolled narrow‑angle glaucoma, and in those for whom the risks of severe sedation, orthostatic hypotension or cardiac effects outweigh potential benefits.